| Filed On | Filing |
|---|---|
| 21 Jan 2025 |
Form 3: Roy Michel, Chief Commercial Officer
Holds 1 shares of Common Stock |
| 09 Feb 2024 |
Form 3: Beaudoin Marc, Chief Operating Officer
No securities owned |
| 26 Oct 2022 |
Form 3: Chamoun Malek, 10% owner
Holds 3,700,000 shares of Common Stock, par value $0.001 per share |
| 18 Feb 2022 |
Form 3: Natan David, Director
Holds 0 shares of Common Stock |
| 18 Feb 2022 |
Form 3: Keller Andrew Mark, Director
Holds 0 shares of Common Stock |
| 16 Dec 2021 |
Form 3: Kiderchah Rabi, Director
Holds 325,000 shares of Common Stock |
| 14 Dec 2021 |
Form 3: Kish James Daniel, Director
Holds 287,100 shares of Common Stock |
| 09 Dec 2021 |
Form 3: Telsey Andrew I, Director
Holds 3,000 shares of Common Stock |
| 02 Aug 2016 |
Form 3: Advanomics Corp, 10% owner
Holds 351,876,192 shares of Common Stock |
| 20 Mar 2015 |
Form 3: Merzouki Abderrazzak, Director
Holds 1,467,000 shares of Common Stock |
| 02 Nov 2009 |
Form 3: Di Turi Michele, Director
Holds 234,373 shares of Common Stock |
| 02 Nov 2009 |
Form 3: Sebaaly Camille, Director
Holds 234,373 shares of Common Stock |
| 02 Nov 2009 |
Form 3: Slilaty Steve N., Director
Holds 234,373 shares of Common Stock |
Loading...